CONCLUSION: Achieving 1 Gy(RBE) BMS for IMPT is feasible for LACC patients with limited dosimetric impact on other OARs. While further bone marrow dose reduction is possible for some patients, it may increase OAR doses substantially for others. Hence, we recommend a personalized approach when introducing BMS into clinical IMPT...
Read more
Published on: 2024-03-12
Source:
Nout Remi
CONCLUSION: This study highlights the complexity, duration and impact on patient experience of the current IGABT workflow. Patient reported pre-treatment pain and anxiety can help identify patients that may benefit from additional support. Research and implementation of measures aiming at shortening the overall procedure duration, which may include logistical, staffing...
Read more
Published on: 2024-02-28
Source:
Nout Remi
CONCLUSION: This study suggests that the toxicity and survival of TT is similar to CRT or LND-CRT....
Read more
Published on: 2024-02-10
Source:
Nout Remi